VALID TRIAL
Both CHIA and your personal trial have the following criteria:
╒════════════════════════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                                  │ CHIA Criteria                                      │   Score │
╞════════════════════════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Non-obese: defined as BMI less than 28 kg/m2       │ Non-obese: defined as BMI less than 28 kg/m2       │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Positive for at least one of the anti-islet        │ Positive for at least one of the anti-islet        │     100 │
│ autoantibodies: GADA, IA2A, ZnT8A                  │ autoantibodies: GADA, IA2A, ZnT8A                  │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Fasting or postprandial plasma C-peptide more than │ Fasting or postprandial plasma C-peptide more than │     100 │
│ 100 pmol/L                                         │ 100 pmol/L                                         │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Written informed consent from the patient or       │ Written informed consent from the patient or       │     100 │
│ family representative                              │ family representative                              │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ History of any malignancy or other severe diseases │ History of any malignancy or other severe diseases │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Female patients who are pregnant or breastfeeding  │ Female patients who are pregnant or breastfeeding  │     100 │
│ before or during the three-year follow-up          │ before or during the three-year follow-up          │         │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Poor compliance or refusal to participate          │ Poor compliance or refusal to participate          │     100 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Age≥ 18 years and less than 70 years               │ Age= 18 years and less than 70 years               │      97 │
├────────────────────────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Type 1 diabetes according to ADA criterias \<5     │ Type 1 diabetes according to ADA criterias <5      │      99 │
│ years                                              │ years                                              │         │
╘════════════════════════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

Only your personal trial has the following criteria:
╒═══════════════════════════════════╤════════════════════════════════════════════════════╤═════════╕
│ Personal Criteria                 │ CHIA Criteria                                      │   Score │
╞═══════════════════════════════════╪════════════════════════════════════════════════════╪═════════╡
│ Must have minimum age of 18 Years │ History of any malignancy or other severe diseases │      39 │
├───────────────────────────────────┼────────────────────────────────────────────────────┼─────────┤
│ Must have maximum age of 70 Years │ Age= 18 years and less than 70 years               │      43 │
╘═══════════════════════════════════╧════════════════════════════════════════════════════╧═════════╛

CHIA has no unique criteria

Levenshtein Ratio of Entire trial at once: 94
Average Levenshtein Ratio of individual lines: 88.9090909090909
OverAll Ratio: 91.45454545454545
